{
    "SPADE_N_13719": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13719",
            "Peptide Name": "Ubericin K (natural AMPs; class 2d Bacteriocin, bacteria, prokaryotes; UCLL1; BBrcp)",
            "Source": "Streptococcus uberisisolated from bovine milk",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "AKGVCKYVYPGSNGYACRYPNGEWGYIVTKSNFEATKDVIVNGWVSSLLGGGYFHGNRG",
            "Sequence Length": 59,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 6409.1,
            "PI": 9.04,
            "Hydrophobicity": -0.34,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Oftedal TF, Ovchinnikov KV, Hestad KA, Goldbeck O, Porcellato D, Narvhus J, Riedel CU, Kjos M, Diep DB. 2021",
                    "Reference": "Microbiol Spectr. 2021 Oct 31; 9(2):e0029921. doi: 10.1128/Spectrum.00299-21.PubMed",
                    "Title": "Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS"
                }
            ],
            "Frequent Amino Acids": "GVY",
            "Absent Amino Acids": "MOQU",
            "Basic Residues": 7,
            "Acidic Residues": 3,
            "Hydrophobic Residues": 25,
            "Polar Residues": 35,
            "Positive Residues": 7,
            "Negative Residues": 3,
            "Net Charge": 4,
            "Comments": "Sequence analysis:  APD analysis reveals this sequence is most similar (38.7%) toCarnobacteriocin BM1GRAVY: -0.33; Mol formula: C291H433N73O83S2; Mol Wt:  6409.182; mol ex coeff:20165.Activity: Spot-om-lawn assay: Active against S. dysgalactiae LMGT 3890 or 3899 (++ small clear zone of inhibition), L. lactis IL1403 (+++ clear zone of inhibition), E. faecalis LMGT 2333 or 3088 (+ visible/diffuse inhibition), E. faecium LMGT 2763 or 2772 (+++), L. lactis IL1403 (+++), L. curvatus LMGT 2353 (++), L. garvieae LMGT 3390 (++), L. monocytogenes LMGT 2651 or 2604 (+++), L. innocua LMGT 2785 (+++), S. uberis LMGT 3912 (+++), no inhibition (-):  B.cereus LMGT 2805 or ATCC 9136B, S.aureus LMGT 3023 or 3242, E.coli TG1.A synthetic version of the peptide showed a similar activity spectrum.MOA: Ubericin K is a pore former targeting the mannose PTS system, similar to Lactococcin A and garvieacin Q. Thus, the petide is inactive against a mutant where the operon encoding the man-PTS system has been deleted.Reg. 10/2021; updated 9/2024",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05591",
                    "Similarity": 0.75,
                    "Sequence": "NGEWGYVVTKGAFQATTDVIANGWVSSLGGGYFGKP"
                }
            ]
        }
    }
}